Condition (MeSH)
Corneal Injuries
ClinicalTrials.gov lists 45 trials for Corneal Injuries or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
38 of the 45 trials are tagged with Corneal Injuries itself; the rest are tagged with a narrower condition beneath it.
When did Corneal Injuries trials start? (16)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 6
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 1 |
| 2024 | 6 |
| 2022 | 3 |
| 2021 | 4 |
| 2020 | 2 |
| 2019 | 3 |
| 2018 | 3 |
| 2017 | 2 |
| 2016 | 4 |
Showing 10 of 16 earlier years.
No forecast is made for this condition: it averages 2.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Corneal Injuries trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 8 |
| Phase 1/2 | 2 |
| Phase 2 | 2 |
| Phase 2/3 | 2 |
| Phase 3 | 2 |
| Phase 4 | 1 |
| Not applicable | 18 |
| Observational | 10 |
How many Corneal Injuries trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 6 |
| Active, not recruiting | 1 |
| Completed | 17 |
| Terminated | 4 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Corneal Injuries trials? (6)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| CorNeat Vision Ltd. | 2 |
| Krystal Biotech, Inc. | 2 |
| Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | 1 |
| Claris Biotherapeutics, Inc. | 1 |
| Farwaniya Hospital | 1 |
Showing 5 of 6 sponsors.
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| C: moxifloxacin | 1 |
| Low dose losartan | 1 |
| Topical Insulin | 1 |
| Ophthalmic Tetracaine | 1 |
| Tetracaine 0.5% ophthalmic drops | 1 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Corneal Injuries trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Choroidal detachment and exudative detachment | 1 | 1 |
| Conjunctival retraction with dehiscence of prosthesis & possible corneal epithelial ingrowth | 1 | 1 |
| Covid 19 Infection | 1 | 1 |
| Dehiscence of prosthesis superiorly | 1 | 1 |
| Exposure of implant | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Corneal Injuries? (77)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics | 2023 | Yes |
| The corneal fibroblast: The Dr. Jekyll underappreciated overseer of the responses to stromal injury. | The ocular surface | 2023 | Yes |
| Antibiotic prophylaxis for corneal abrasion. | The Cochrane database of systematic reviews | 2022 | Yes |
| Village-integrated eye workers for prevention of corneal ulcers in Nepal (VIEW study): a cluster-randomised controlled trial. | The Lancet. Global health | 2022 | Yes |
| Community Health Workers for Prevention of Corneal Ulcers in South India: A Cluster-Randomized Trial. | American journal of ophthalmology | 2022 | Yes |
Showing 5 of 77 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.